
Immunising infants and older people against RSV found to not be cost-effective - HIQA
28/04/2026
0:00
2:54
Dr. Máirín Ryan, HIQA Director of Health Technology Assessment, explains its assessment of immunisation programmes against RSV.
See omnystudio.com/listener for privacy information.
Mais episódios de "Morning Ireland"



Não percas um episódio de “Morning Ireland” e subscrevê-lo na aplicação GetPodcast.








